Hikari Tsushin Inc’s Bristol-Myers Squibb BMY Stock Holding History

Hikari Tsushin Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.68M	Hold	81,141	–	–	0.31%	27
2026 Q1	$4.92M	Hold	81,141	–	–	0.34%	26
2025 Q4	$4.38M	Hold	81,141	–	–	0.29%	31
2025 Q3	$3.66M	Hold	81,141	–	–	0.25%	34
2025 Q2	$3.76M	Hold	81,141	–	–	0.26%	34
2025 Q1	$4.95M	Hold	81,141	–	–	0.33%	29
2024 Q4	$4.59M	Hold	81,141	–	–	0.33%	31
2024 Q3	$4.2M	Hold	81,141	–	–	0.3%	33
2024 Q2	$3.37M	Hold	81,141	–	–	0.26%	34
2024 Q1	$4.4M	Hold	81,141	–	–	0.35%	32
2023 Q4	$4.16M	Hold	81,141	–	–	0.38%	29
2023 Q3	$4.71M	Hold	81,141	–	–	0.46%	25
2023 Q2	$5.19M	Hold	81,141	–	–	0.5%	26
2023 Q1	$5.62M	Hold	81,141	–	–	0.59%	23
2022 Q4	$5.84M	Hold	81,141	–	–	0.62%	22
2022 Q3	$5.77M	Hold	81,141	–	–	0.7%	20
2022 Q2	$6.25M	Hold	81,141	–	–	0.82%	18
2022 Q1	$5.93M	Hold	81,141	–	–	0.6%	22
2021 Q4	$5.06M	Buy	+81,141	New	+$4.76M	0.55%	23
2021 Q2	$476K	Buy	+7,120	New	+$464K	0.06%	37

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hikari Tsushin Inc's BMY Position: Q2 2026 in Review

Hikari Tsushin Inc held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 81,141 shares worth $4.68M. The position accounts for 0.31% of the portfolio, ranked #27.

Hikari Tsushin Inc first reported a position in BMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $6.25M in Q2 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hikari Tsushin Inc held 81,141 shares of Bristol-Myers Squibb worth $4.68M as of Q2 2026.
Hikari Tsushin Inc left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.31% of Hikari Tsushin Inc's portfolio in Q2 2026, its #27 holding.
Hikari Tsushin Inc first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 20 quarters since.
Hikari Tsushin Inc's Bristol-Myers Squibb position peaked at $6.25M in Q2 2022.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hikari Tsushin Inc's 13F filing for Q2 2026, filed 12 Aug 2026.